Oral Presentation: Five Hematologic Malignancies Studies by Leads Biolabs to Be Featured at ASH 2025
Leads Biolabs (Stock Code: 9887.HK) today announced that five research abstracts from its hematological oncology portfolio—includin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback